S100A6 and cancer: Another study (n = 80) showed a non-significant discordance rate of 8.2% in ER (lower ER expression in recurrent cancers) and a significant discordance rate of 15.7% in PRa (lower PRa expression in recurrent platinum-sensitive cancers) [32].